Select Committee on Biotechnology

State Assembly Declares April 7th Biotechnology Day

(Sacramento) – Assemblymember Kevin Mullin (D-San Mateo) and State Senator Jerry Hill joined together to author Senate Concurrent Resolution 120, which declares April 7, 2016 as Biotechnology Day in California. During a ceremony on the Assembly floor, Assemblymember Mullin said, “There are nearly 3-thousand life sciences companies in our state. They directly employ over 280-thousand individuals and generate $130-billion in revenue.” Here’s more from Assemblymember Mullin in this Assembly Access video.


Mullin Honors Biotechnology Giant Genentech

(Sacramento) – Assemblymember Kevin Mullin (D-San Mateo) took to the Assembly floor to honor the founder of California’s biotech industry, Genentech, California’s first biotech company. Founded 40 years ago and headquartered in South San Francisco, Genentech employs nearly 12,000 and has facilities in Vacaville and Oceanside as well. “Genentech has created an industry that has helped millions of patients and fundamentally changed the way serious diseases are treated,” said Assemblymember Mullin. “Just since 2010 Genentech has had nine approvals for new medicines and has received 13 Breakthrough Therapy Designations.” Learn more in this Assembly Access video.


Research & Development, Manufacturing, and the Marketplace in California

On February 12, 2014, the Assembly Select Committee on Biotechnology hosted an Informational Hearing on emerging research in the biotechnology field. Experts from the industry informed members about what California is doing to foster a pioneering economy in research and development, manufacturing, and the marketplace.

See below for resources from that hearing.

View Meeting Agenda

(Sacramento) – Assemblymember Kevin Mullin (D-San Mateo), Chair of the Assembly Select Committee on Biotechnology recently hosted the first of what’s expected to be several hearings on emerging research in the biotechnology field. The hearings will be held throughout California. In the hearing at the State Capitol in Sacramento industry experts informed members about what California is doing to foster a pioneering economy in research and development, manufacturing, and the marketplace.  Assemblymember Mullin says, “It’s my hope that these discussions will lay the foundation to a greater understanding toward creating sound policies that help the innovation economy flourish.” Here’s more in this Assembly Access video.

Assemblymembers Wilk, Fong, Mullin, Harkey, and Wieckowski listen to testimony from representatives of the University of California, San Francisco and Boehringer Ingelheim.


Assemblymembers Wilk, Fong, Mullin, Harkey, Maienschein, and Gordon listen to testimony from representatives of the University of Southern California and Pfizer Oncology.


Keeping California on the Leading Edge of the Biotech Frontier

(Sacramento) - State Assemblymember Kevin Mullin (D-South San Francisco), Chair of the Assembly Select Committee on Biotechnology, knows the value of California’s biotechnology industry and he wants California to remain a hub for innovation. In an interview with the California Biotechnology Foundation in January 2015, Assemblymember Mullin said, “We must continue our efforts to ensure that California remains a leader for biotechnology, high technology , clean-technology and life sciences.” Watch the CBF interview in this Assembly Assets video.